Your browser doesn't support javascript.
loading
Pre-Treatment Hemoglobin Concentration and Absolute Monocyte Count as Independent Prognostic Factors for Survival in Localized or Locally Advanced Prostate Cancer Patients Undergoing Radiotherapy.
Magrowski, Lukasz; Masri, Oliwia; Ciepal, Jakub; Depowska, Gabriela; Nowicka, Zuzanna; Stando, Rafal; Chimiak, Krystyna; Bylica, Gabriela; Czapla, Barbara; Masri, Malgorzata; Cichur, Franciszek; Jablonska, Iwona; Gmerek, Marta; Wojcieszek, Piotr; Krzysztofiak, Tomasz; Sadowski, Jacek; Suwinski, Rafal; Rajwa, Pawel; Moll, Matthias; Goldner, Gregor; Majewski, Wojciech; Miszczyk, Marcin.
Afiliación
  • Magrowski L; IIIrd Department of Radiotherapy and Chemotherapy, Maria Sklodowska-Curie National Research Institute of Oncology, 44-102 Gliwice, Poland.
  • Masri O; IIIrd Department of Radiotherapy and Chemotherapy, Maria Sklodowska-Curie National Research Institute of Oncology, 44-102 Gliwice, Poland.
  • Ciepal J; IIIrd Department of Radiotherapy and Chemotherapy, Maria Sklodowska-Curie National Research Institute of Oncology, 44-102 Gliwice, Poland.
  • Depowska G; IIIrd Department of Radiotherapy and Chemotherapy, Maria Sklodowska-Curie National Research Institute of Oncology, 44-102 Gliwice, Poland.
  • Nowicka Z; Department of Biostatistics and Translational Medicine, Medical University of Lodz, 90-419 Lodz, Poland.
  • Stando R; Department of Radiotherapy, Holy Cross Cancer Center, 25-734 Kielce, Poland.
  • Chimiak K; IIIrd Department of Radiotherapy and Chemotherapy, Maria Sklodowska-Curie National Research Institute of Oncology, 44-102 Gliwice, Poland.
  • Bylica G; IIIrd Department of Radiotherapy and Chemotherapy, Maria Sklodowska-Curie National Research Institute of Oncology, 44-102 Gliwice, Poland.
  • Czapla B; IIIrd Department of Radiotherapy and Chemotherapy, Maria Sklodowska-Curie National Research Institute of Oncology, 44-102 Gliwice, Poland.
  • Masri M; IIIrd Department of Radiotherapy and Chemotherapy, Maria Sklodowska-Curie National Research Institute of Oncology, 44-102 Gliwice, Poland.
  • Cichur F; IIIrd Department of Radiotherapy and Chemotherapy, Maria Sklodowska-Curie National Research Institute of Oncology, 44-102 Gliwice, Poland.
  • Jablonska I; IIIrd Department of Radiotherapy and Chemotherapy, Maria Sklodowska-Curie National Research Institute of Oncology, 44-102 Gliwice, Poland.
  • Gmerek M; IIIrd Department of Radiotherapy and Chemotherapy, Maria Sklodowska-Curie National Research Institute of Oncology, 44-102 Gliwice, Poland.
  • Wojcieszek P; Brachytherapy Department, Maria Sklodowska-Curie National Research Institute of Oncology Gliwice Branch, 44-102 Gliwice, Poland.
  • Krzysztofiak T; Brachytherapy Department, Maria Sklodowska-Curie National Research Institute of Oncology Gliwice Branch, 44-102 Gliwice, Poland.
  • Sadowski J; Department of Radiotherapy, Holy Cross Cancer Center, 25-734 Kielce, Poland.
  • Suwinski R; II Clinic of Radiotherapy and Chemotherapy, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, 44-102 Gliwice, Poland.
  • Rajwa P; Department of Urology, Comprehensive Cancer Center, Vienna General Hospital, Medical University of Vienna, Währinger Gürtel 18-20, 1090 Vienna, Austria.
  • Moll M; Department of Urology, Medical University of Silesia, 3-go Maja 13-15, 41-800 Zabrze, Poland.
  • Goldner G; Department of Radiation Oncology, Comprehensive Cancer Center, Medical University of Vienna, Währinger Gürtel 18-20, 1090 Vienna, Austria.
  • Majewski W; Department of Radiation Oncology, Comprehensive Cancer Center, Medical University of Vienna, Währinger Gürtel 18-20, 1090 Vienna, Austria.
  • Miszczyk M; Radiotherapy Department, Maria Sklodowska-Curie National Research Institute of Oncology, Wybrzeze Armii Krajowej 15, 44-102 Gliwice, Poland.
Biomedicines ; 10(10)2022 Oct 08.
Article en En | MEDLINE | ID: mdl-36289778

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Biomedicines Año: 2022 Tipo del documento: Article País de afiliación: Polonia Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Biomedicines Año: 2022 Tipo del documento: Article País de afiliación: Polonia Pais de publicación: Suiza